Teva Pharmaceutical (TEVA) Amends Credit Facility, Extends Maturity to 2028
Teva Pharmaceutical (TEVA) amended its revolving credit agreement, extending the maturity date to April 29, 2028, and adjusting financial covenants.
Financing
Alnylam Pharmaceuticals (ALNY) Repurchases $34.4 Million in Convertible Notes for $51.9 Million
Alnylam Pharmaceuticals (ALNY) repurchased $34.4 million in convertible notes for $51.9 million, according to an SEC 8-K filing.
Structure Therapeutics (GPCR) Completes $650 Million Follow-On Offering
Structure Therapeutics Inc. (GPCR) completed a $650 million follow-on public offering of ADSs and pre-funded warrants.
Moleculin Biotech (MBRX) Secures $6.8 Million Through Warrant Inducement Offer
Moleculin Biotech (MBRX) entered into warrant exercise inducement offers, generating $6.8 million in gross proceeds.
Factual headline with ticker: Oncotelic Therapeutics (OTLC) Completes $275,000 Private Placement Offering
Oncotelic Therapeutics (OTLC) completed a $275,000 private placement offering of 11 units to accredited investors on December 4, 2025.